Reproductive experience modulates dopamine-related behavioral responses

Pharmacology Biochemistry and Behavior

Volumn 68, Issue 3, 2001, Pages 575-582

  Hucke, Erica E T S ^a   Cruz Casallas, Pablo E ^a   Sider, Lúcia H ^a   Felicio, Luciano F ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSIDAD DE LOS LLANOS   (Colombia)

Author keywords

Dopamine; Hypothermia; Motor activity; Parity; Stereotypy

Indexed keywords

AMPHETAMINE; APOMORPHINE; DOPAMINE RECEPTOR; HALOPERIDOL; METOCLOPRAMIDE; PROLACTIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG WITHDRAWAL; ENVIRONMENT; FEMALE; HORMONAL REGULATION; HYPOTHERMIA; LACTATION; MATING; NEUROMODULATION; NONHUMAN; OVARIECTOMY; PARITY; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RAT; SEXUAL BEHAVIOR; STEREOTYPY; STRESS; WITHDRAWAL SYNDROME;

AMPHETAMINE; ANIMALS; APOMORPHINE; BEHAVIOR, ANIMAL; BODY TEMPERATURE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HYPOTHALAMUS; MOTOR ACTIVITY; OVARIECTOMY; PARITY; PREGNANCY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE; REPRODUCTION; SEXUAL BEHAVIOR, ANIMAL;

EID: 0034998664     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(01)00458-0     Document Type: Article

References (67)

1. Barr AM, Phillips AG. Withdrawal following repeated exposure to D-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement. Psychopharmacology (Berlin) 1999;141(1):99-106.
2. Ben-Jonathan N, Arbogast LA, Hyde JF. Neuroendocrine regulation of prolactin release. Prog Neurobiol 1979;33:399-477.
3. Bjorklund A, Flack B, Nobin A, Stenevi U. Organization of the dopamine and noradrenaline innervation of the median eminence-pituitary region in the rat. In: Knowles F, Vollarath L, editors. Neurosecretion: the final pathway. New York: Springer-Verlag, 1974. p. 209.
4. Bridges RS, Felicio LF, Pellerin LJ, Stuer AM, Mann PE. Prior parity reduces post-coital diurnal and nocturnal prolactin surges in rats. Life Sei 1993;53:439-45.
5. Bridges RS, Henriquez BM, Sturgis JD, Mann PE. Reproductive experience reduces haloperidol-induced prolactin secretion in females rats. Neuroendocrinology 1997;66(5):321 -6.
6. Broadhurst PL. Experiments in psychogenetics. In: Eysenk HJ, editor. Experiments in personality, vol. 1. London: Routledge and Kegan Paul, 1960. pp. 3-102.
7. Byrnes EM, Bridges RS. Parity potentiates the effects of apomorphine on sensorimotor gating and stereotypy. Soc Neurosci Abstr 1999;25:2137.
8. Caul WF, Stadler JR, Barrett RJ. Amphetamine-induced withdrawal responding: effects of repeated drug administration. Psychopharmacology (Berlin) 1997;133(4):351-5.
9. Chen JC, Huang LI, Hsieh MM. Reductions in binding and functions of D2 dopamine receptors in the rat ventral striatum during amphetamine sensitization. Life Sei 1999;64(5):343-54.
10. Clark D, Furmidge LJ, Perry N, Tong ZY, Ericsson M, Johnson D. Behavioral profile of partial D2 dopamine receptor agonists. Psychopharmacology 1991;105:381-92.
11. Cohen J, Bridges RS. Retention of maternal behavior in nulliparous and primiparous rats: effects of duration of previous maternal experience. J Comp Psychol 1981;95:450-9.
12. Cole P, Brown JB, MacMahon B. Oestrogen profiles of parous and nulliparous women. Lancet 1976;2:596.
13. Cote L, Crutcher MD. The basal ganglia. In: Kandel ER, Schwartz JH, Jessel TM, editors. Principles of neural science. USA: Appleton & Lange, 1991. pp. 647-59.
14. De Los Monteras AE, Cornejo J, Parra A. Differential prolactin response to oral metoclopramide in nulliparous versus parous women throughout the menstrual cycle. Fertil Steril 1991;55:885-9.
15. A receptors. Pharmacol, Biochem Behav 1999;62(l):31-7.
16. Escalada J, Cacicedo L, Ortego J, Melian E, Sanchez-Franco F. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide. Endocrinology 1996;137:631-7.
17. Felicio LF, Nasello AG, Palermo-Neto J. Dopaminergic supersensitivity after long-term bromopride treatment. Physiol Behav 1987;41:433-7.
18. Felicio LF, Palermo-Neto J, Nasello AG. Perinatal bromopride treatment: effects on motor activity and stereotyped behavior of offspring. Physiol Behav 1989;45:1081-5.
19. Felicio LF, Florio JC, Sider LH, Cruz-Casallas PE, Bridges RS. Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats. Brain Res Bull 1996;40:253-6.
20. Fiorino DF, Phillips AG. Facilitation of sexual behavior and enhanced efflux in the nucleus accumbens of male rats after D-amphetamineinduced behavioral sensitization. J Neurosci 1999;19(1):456-63.
21. Fray PJ, Sahakian BJ, Robbins TW, Kobb GF, Iversen SD. An observation method for quantifying the behavioral effects of dopamine agonists: contrasting effects of d-amphetamine and apomorphine. Psychopharmacology 1980;69:253-9.
22. Ghez C, Gordon J. Voluntary movement. In: Kandel ER, Schwartz JH, Jessel TM, editors. Essentials of neural science and behavior. USA: Appleton & Lange, 1995. pp. 529-49.
23. Hucke EETS, Cruz-Casallas PE, Florio JC, Felicio LF, Bridges RS. Prior parity reduces the light-dark shift-related increase in striatal dopaminergic and serotoninergic activity in rats as measured using in vivo microdialysis. NeuroReport 1998;9:3589-93.
24. Hucke EETS, Florio JC, Felicio LF. Neurochemical changes induced by reproductive experience in female rats. Soc Neurosci Abstr 1999;25:2136.
25. Joseph JA, Kochman K, Roth GS. Reduction of motor behavioral deficits in senescence via chronic prolactin or estrogen administration: time course and putative mechanisms of action. Brain Res 1989;505(2): 195-202.
26. Keefe DL, Michelson DS, Lee SH, Naftolin F. Astrocytes within the hypothalamic arcuate nucleus contain estrogen-sensitive peroxidase, bind fluorescein-conjugated estradiol, and may mediate synaptic plasticity in the rat. Am J Obstet Gynecol 1991;164(4):959-66.
27. Kihara T, Ikeda M, Matsubara K, Matsushita A. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat. Eur J Pharmacol 1993;230:271-7.
28. Kinsley CH, Bridges RS. Parity-associated reduction in behavioral sensitivity to opiates. Biol Reprod 1988;39:270-8.
29. Kinsley CH, Madonia L, Gifford GW, Tureski K, Griffin GR, Lowry C, Williams J, Collins J, McLearie H, Lambert KG. Motherhood improves learning and memory. Nature 1999;402:137-8.
30. Kolb B, Forgie M, Gibb R, Gorny G, Rowntree S. Age, experience and the changing brain. Neurosci Biobehav Rev 1998;22(2):143-59.
31. Laudrup P, Wallace LJ. Sensitization elicited by directly and indirectly acting dopaminergic agonists: comparisons using neural network analysis. Psychopharmacology (Berlin) 1991;141(2):169-74.
32. Lee A, Clancy S, Fleming AS. Mother rats bar-press for pups: effects of lesions of the mpoa and limbic sites on maternal behavior and operant responding for pup-reinforcement. Behav Brain Res 1999a; 100(1-2):15-31.
33. Lee A, Li M, Watchus J, Fleming AS. Neuroanatomical basis of maternal memory in postpartum rats: selective role for the nucleus accumbens. Behav Neurosci 1999b;113(3):523-38.
34. Ljunberg T, Ungerstedt U. Differential behavioral patterns induced by apo-morphine: evidence that the method of administration determines the behavioral response to the drug. Eur J Pharmacol 1977;46:41-50.
35. Ljunberg T, Ungerstedt U. Classification of neuroleptic drugs according to their ability to inhibit apomorphine-induced locomotion and gnawing: evidence for two different mechanisms of action. Psychopharmacology 1978;56:239-47.
36. Mann PE, Bridges RS. Neural and endocrine sensitivities to opioids decline as a function of multiparity in the rat. Brain Res 1992;580:241-8.
37. Mann PE, Kinsley CH, Ronsheim PM, Bridges RS. Long-term effects of parity on opioid behavioral and endocrine responses. Pharmacol, Biochem Behav 1989;34:83-8.
38. Mason ST. Catecholamines and motor behavior. Catecholamines and behavior. London: Cambridge Univ. Press, 1984. pp. 96-176.
39. McEwen BS. Steroid hormones and the brain: linking "nature" and "nurture". Neurochem Res 1988;13(7):663-9.
40. McEwen BS. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991;12:141-7.
41. McEwen BS, Coirini H, Westlind-Danielson A, Frankfurt M, Gould E, Schumacher M, Woolley C. Steroid hormones as mediators of neural plasticity. J Steroid Biochem Mol Biol 1991;39:223-32.
42. Mohankumar PS, Mohankumar SMJ, Quadri SK, Voogt JL. Chronic hyperprolactinemia and changes in dopamine neurons. Brain Res Bull 1997;42(6):435-41.
43. Mueller K, Whiteside DA. Enkephalin prevents CCK-induced enhancement of amphetamine-induced locomotor stereotypy. Brain Res 1990;513:119-24.
44. Musey VC, Collins DC, Brogan DR, Santos VR, Musey PI, Martino-Saltzman D, Preedy JRK. Long term effects of the first pregnancy on the hormonal environment: estrogens and androgens. J Clin Endocrinol Metab 1987a;64:111-8.
45. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JRK. Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 1987b;316:229-34.
46. Onaivi ES. APO induced hypothermia, stereotypy and changes in dopamine D2 mRNA expression. NeuroReport 1997;4:703-5.
47. Palermo-Neto J. Supersensitivity, drug withdrawal and open-field behavior. Psychopharmacol Bull 1984;18:11-2.
48. Paulson PE, Robinson TE. Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automed on-line microdialysis. Neuropsychopharmacology 1996;14(5):325-37.
49. Paulson PE, Camp DM, Robinson TE. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 1991;103:480-92.
50. Robbins TW. The acquisition of responding with conditioned reinforcement: effects of pipradol, metylphenidate, D-amphetamine, and nomifensine. Psychopharmacology 1978;58:79-87.
51. Role LW, Kelly JP. The brain stem. In: Kandel ER, Schwartz JH, Jessel TM, editors. Principles of neural science. USA: Appleton & Lange, 1991. pp. 683-99.
52. Schindler CW, Persico AM, Uhl GR, Goldberg SR. Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions. Pharmacol, Biochem Behav 1994;49(1):41-6.
53. Setler P, Sarau H, McKenzie G. Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur J Pharmacol 1976;39: 117-26.
54. Suva MRP, Bernardi MM, Nasello AG, Felicio LF. Influence of lactation on motor activity and elevated plus maze behavior. Braz J Med Biol Res 1997;30:241-4.
55. Standaert DG, Young AB. Treatment of central nervous system degenerative disorders. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman & Gilman's The pharmacological basis of therapeutics 9th ed. McGraw-Hill, USA. 1996;503-20.
56. Tieppo CA, Silva AMP, Palermo-Neto J, Nasello AG, Felicio LF. Intracereborventricular administration of cholecystokinin reduces stereotypy in dopamine-supersensitive rats. Braz J Med Biol Res 1995;28:351-4.
57. Tieppo CA, Nasello AG, Felicio LF. Modulation of apomorphine-induced stereotyped behavior by cholecystokinin. Prog Neuro-Psychopharmacol Biol Psychiatry 1997;21:683-95.
58. 2 antagonists. Eur J Pharmacol 2000;387: 189-96.
59. Trichopoulus D, Cole P, Brown JB, Goldman MB, MacMahon B. Estrogen profiles of primiparous and nulliparous women in Athens, Greece. J Natl Cancer Inst 1980;65:43.
60. Troncone LRP, Ferreira TMS, Braz S, Silveira-Filho NG, Tufik S. Reversal of increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonists pretreatment. Psychopharmacology 1988;94:79-83.
61. Ungerstedt U. Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand 1971;367:l-48 (Supplement).
62. Vanzeler MLA, Felicio LF, Nasello AG. Effects of acute domperidone treatment on several behavioral parameters and thermoregulation in male rats. Neuroendocrinol Lett 1990;12(4):334.
63. Vleugels MP, Eling WM, Roland R, De Graaf R. Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol 1986; 155:118.
64. Wang DYZ, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Verstraeten AA, Moore JW, Fentiman IS. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol 1988;24:1225.
65. Wise RA, Munn E. Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology (Berlin) 1995;117(2):130-6.
66. Zabavnik J, Wu WX, Eidne KA, McNeilly AS. Dopamine D2 receptor mRNA in the pituitary during the oestrous cycle, pregnancy and lactation in the rat. Mol Cell Endocrinol 1993;95:121-8.
67. Zuppa AA, Tornesello A, Papacci P, Tortorolo G, Segni G, Moneta E, Diodato A. Relationship between maternal parity, basal prolactin levels and neonatal breast milk intake. Biol Neonate 1988;53:144.